Coon et al., 2005 - Google Patents
Possible association between autism and variants in the brain‐expressed tryptophan hydroxylase gene (TPH2)Coon et al., 2005
- Document ID
- 2988583718963961350
- Author
- Coon H
- Dunn D
- Lainhart J
- Miller J
- Hamil C
- Battaglia A
- Tancredi R
- Leppert M
- Weiss R
- McMahon W
- Publication year
- Publication venue
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
External Links
Snippet
We report a possible association between autism in our sample and a recently described brain‐expressed tryptophan hydroxylase gene (TPH2). The well‐replicated involvement of the serotonin neurotransmitter system in autism has stimulated interest in many genes in the …
- 206010003805 Autism 0 title abstract description 77
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Coon et al. | Possible association between autism and variants in the brain‐expressed tryptophan hydroxylase gene (TPH2) | |
| Cavallini et al. | Exploratory factor analysis of obsessive‐compulsive patients and association with 5‐HTTLPR polymorphism | |
| Correia et al. | Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF/TrkB signaling in autism | |
| Mill et al. | Association study of a SNAP‐25 microsatellite and attention deficit hyperactivity disorder | |
| Eley et al. | Association analysis of MAOA and COMT with neuroticism assessed by peers | |
| Alsobrook et al. | Association between the COMT locus and obsessive‐compulsive disorder in females but not males | |
| Quillen et al. | ALDH2 is associated to alcohol dependence and is the major genetic determinant of “daily maximum drinks” in a GWAS study of an isolated rural Chinese sample | |
| Anitha et al. | Genetic analyses of roundabout (ROBO) axon guidance receptors in autism | |
| Yan et al. | Using genetic information from candidate gene and genome‐wide association studies in risk prediction for alcohol dependence | |
| Zabost et al. | Correlation of N‐acetyltransferase 2 genotype with isoniazid acetylation in polish tuberculosis patients | |
| Kim et al. | Investigation of variation in SNAP‐25 and ADHD and relationship to co‐morbid major depressive disorder | |
| Kamien et al. | Characterization of a 520 kb deletion on chromosome 15q26. 1 including ST8SIA2 in a patient with behavioral disturbance, autism spectrum disorder, and epilepsy | |
| Smith et al. | Family‐Based Clinical Associations and Functional Characterization of the Serotonin 2 A Receptor Gene (HTR2A) in Autism Spectrum Disorder | |
| Mas et al. | Role of GAD2 and HTR1B genes in early‐onset obsessive‐compulsive disorder: results from transmission disequilibrium study | |
| Yamamoto et al. | Dopamine beta‐hydroxylase (DBH) gene and schizophrenia phenotypic variability: A genetic association study | |
| Williams et al. | Detailed analysis of PRODH and PsPRODH reveals no association with schizophrenia | |
| Seripa et al. | Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life | |
| Qadri et al. | Genetic polymorphisms in the dopamine receptor 2 predict acute pain severity after motor vehicle collision | |
| Vanyukov et al. | Haplotypes of the monoamine oxidase genes and the risk for substance use disorders | |
| Li et al. | Contribution of 5‐HT2A receptor gene‐1438A> G polymorphism to outcome of attention‐deficit/hyperactivity disorder in adolescents | |
| Fullerton et al. | Assessing oxidative pathway genes as risk factors for bipolar disorder | |
| Jamerson et al. | Folate metabolism genes, dietary folate and response to antidepressant medications in late‐life depression | |
| Rubin et al. | Candidate gene associations with withdrawn behavior | |
| Griswold et al. | A de novo 1.5 Mb microdeletion on chromosome 14q23. 2‐23.3 in a patient with autism and spherocytosis | |
| Wang et al. | Gender differences in genetic linkage and association on 11p15 in obsessive–compulsive disorder families |